ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.106,22
0,18%
S&P 500
5.473,23
0,00%
Dow Jones
38.778,10
0,00%
Euro vs US Dollar
1,07306
-0,09%
Bitcoin
65.134,15
-2,03%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) News

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AEMD
DatumZeitQuelleÜberschriftSymbolFirma
18/06/202414h01PR Newswire (US)Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialNASDAQ:AEMDAethlon Medical Inc
03/06/202414h01PR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
24/05/202419h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
17/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
17/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
17/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
16/05/202422h05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:AEMDAethlon Medical Inc
16/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
15/05/202415h27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEMDAethlon Medical Inc
15/05/202415h15PR Newswire (US)Aethlon Medical Announces Pricing of $4.7 Million Public OfferingNASDAQ:AEMDAethlon Medical Inc
13/05/202423h30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AEMDAethlon Medical Inc
10/05/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
10/05/202414h01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202414h01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
14/02/202423h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
14/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/02/202422h15PR Newswire (US)Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
07/02/202414h00PR Newswire (US)Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024NASDAQ:AEMDAethlon Medical Inc
03/01/202400h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
03/01/202400h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
03/01/202400h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
22/12/202322h01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AEMDAethlon Medical Inc
27/11/202313h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/11/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
14/11/202322h15PR Newswire (US)Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
13/11/202314h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
13/11/202314h01PR Newswire (US)Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating OfficerNASDAQ:AEMDAethlon Medical Inc
06/11/202314h01PR Newswire (US)Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023NASDAQ:AEMDAethlon Medical Inc
10/10/202314h01PR Newswire (US)Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyNASDAQ:AEMDAethlon Medical Inc
04/10/202323h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
 Showing the most relevant articles for your search:NASDAQ:AEMD

Kürzlich von Ihnen besucht

LSE
TB01
Citi Fun 25
LSE
IE74
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten